Documents (103) JSON TSV

source DB	source ID	text	size	updated at	# proj.	updated_at
PubMed	27023913	ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression. Mutations in LR RK2 (Leu	1.32 KB	2020-01-22	7	-
PubMed	26931464	Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf	2.03 KB	2020-01-21	7	-
PubMed	19667187	R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Dominantly inherited mutati	1.42 KB	2020-01-21	7	-
PubMed	20659558	Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human	1.5 KB	2020-01-21	7	-
PubMed	28973664	LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDN	1.71 KB	2020-01-29	7	-
PubMed	22166430	Mouse models for LRRK2 Parkinson's disease. Parkinson's disease (PD) is the second most common neuro	1.16 KB	2020-01-29	8	-
PubMed	27063942	Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-trans	2.62 KB	2020-01-22	8	-
PubMed	18258746	A Drosophila model for LRRK2-linked parkinsonism. Mutations in the leucine-rich repeat kinase (LRRK2	1.27 KB	2020-01-21	8	-
PubMed	26253900	G2019S LRRK2 and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigros	1.59 KB	2020-01-21	8	-
PubMed	27364102	LRRK2 interferes with aggresome formation for autophagic clearance. Autosomal-dominant mutations in	1.81 KB	2020-01-22	8	-